CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

Abroad (travel likely)Recruiting

Conditions

Lymphoma, B-Cell · Acute Lymphoblastic Leukemia, Pediatric

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hong Kong Children's Hospital, Hong Kong, Hong Kong
Contact: Study coordinator (Daniel Cheuk, MBBS) · cheukkld@ha.org.hk · 852-35136049

Study leads

Pamela Lee, MD
Principal Investigator
The University of Hong Kong

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies

Acute Lymphoblastic Leukemia · Non-Hodgkin Lymphoma of Soft Tissue

Abroad (travel likely)RecruitingEARLY_PHASE1

Hangzhou, China

A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy

Large B-cell Lymphoma · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · Atlanta, United States

Prospective Observational Study of Diffuse Large-cell B Lymphoma

Lymphoma, B-Cell

Abroad (travel likely)Recruiting

Charleroi, Belgium